Matches in Nanopublications for { ?s ?p "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP712913.RAdaoWsB_6KVq3v6tXuGaNiIHXrdZN9KcMBIKdWVi7jOU130_assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712913.RAdaoWsB_6KVq3v6tXuGaNiIHXrdZN9KcMBIKdWVi7jOU130_provenance.
- assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP770697.RAJSFmUdwkVzYGtFDhELe57UFWFYD6fcABONklj70fPG4130_assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770697.RAJSFmUdwkVzYGtFDhELe57UFWFYD6fcABONklj70fPG4130_provenance.
- NP771323.RAHN8hdZ4QH6yOHAEobux4L55CLz4XsXRH01nQ9fI9hhY130_assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771323.RAHN8hdZ4QH6yOHAEobux4L55CLz4XsXRH01nQ9fI9hhY130_provenance.
- NP1200232.RANeoKUoz_CtaURpId4tqA_BzPN4Ep1dYCaJx-Id8cKFo130_assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1200232.RANeoKUoz_CtaURpId4tqA_BzPN4Ep1dYCaJx-Id8cKFo130_provenance.
- NP1200230.RA6mGS-EsAvxH1Zsk_Ytj_gnu3scuKJHZ1LAHbz8xkV8c130_assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1200230.RA6mGS-EsAvxH1Zsk_Ytj_gnu3scuKJHZ1LAHbz8xkV8c130_provenance.
- NP1200233.RA7IBXRnf3omSQPposh_wi-t7RXqvB4p0ZS3_iOin9YY0130_assertion description "[In both uveal and cutaneous melanoma cell lines, SRPK1 was highly expressed, and inhibition of SRPK1 by knockdown or with pharmacological inhibitors reduced pro-angiogenic VEGF expression maintaining the production of anti-angiogenic VEGF isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1200233.RA7IBXRnf3omSQPposh_wi-t7RXqvB4p0ZS3_iOin9YY0130_provenance.